Opportunity Information: Apply for PAR 19 312
Apply for PAR 19 312
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2019-07-10.
- Applicants must submit their applications by 2021-09-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2024.)
- Eligible applicants include: Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: FY 2019 Citizenship and Assimilation Grant Program: Citizenship Instruction and Naturalization Application Services
Previous opportunity: Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 312
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 312) also looked into and applied for these:
| Funding Opportunity |
|---|
| Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 315 Funding Number: PAR 19 315 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 19 011 Funding Number: RFA RM 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) Apply for PAR 19 311 Funding Number: PAR 19 311 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 19 313 Funding Number: PAR 19 313 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 20 001 Funding Number: RFA AA 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) Apply for RFA AA 20 002 Funding Number: RFA AA 20 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 19 314 Funding Number: PAR 19 314 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Partnerships Initiative (NPI) – Global Health Apply for 7200AA19APS00013 Funding Number: 7200AA19APS00013 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Connecting Kids to Coverage (CKC) HEALTHY KIDS AI/AN Apply for CMS 2D2 20 001 Funding Number: CMS 2D2 20 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $750,000 |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Apply for PAS 19 316 Funding Number: PAS 19 316 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) Apply for PAS 19 317 Funding Number: PAS 19 317 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 20 011 Funding Number: RFA AG 20 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 20 010 Funding Number: RFA AG 20 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 030 Funding Number: RFA AG 20 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21) Apply for RFA AT 20 001 Funding Number: RFA AT 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 19 328 Funding Number: PAR 19 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 19 329 Funding Number: PAR 19 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 19 330 Funding Number: PAR 19 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required Apply for PAR 19 335 Funding Number: PAR 19 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 044 Funding Number: RFA AG 20 044 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 312", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.